About the Company - Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 272.80 Cr. and Equity Capital is Rs. 22.36 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Mr. Vasant Rathi | Non Executive Chairman |
Mr. Mukund M Kabra | Whole Time Director |
Ms. Rasika Rathi | Non Executive Director |
Dr. Sunny Sharma | Non Executive Director |
Mr. Kedar Jagdish Desai | Independent Director |
Mr. Pramod Kasat | Independent Director |
Ms. Vandana Tilak | Independent Director |
Mr. Vinodkumar Jajoo | Independent Director |
Ms. Rajshree Patel | Independent Director |
Mr. Nitin Desmukh | Independent Director |
Advanced Enzyme Technologies Ltd. Share Price Update |
---|
Share Price | Value |
---|
Today | ₹355.55 |
Previous Day | ₹360.00 |
Basic Stock Data of Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Ltd Quarterly Results
Advanced Enzyme Technologies Ltd Quarterly Chart
Advanced Enzyme Technologies Ltd Profit & Loss
Advanced Enzyme Technologies Ltd Profit & Loss Yearly Chart
Advanced Enzyme Technologies Ltd Growth
|
Compounded Sales Growth |
---|
10 Years:: | 9% |
5 Years:: | 7% |
3 Years:: | 7% |
TTM:: | 12% |
Advanced Enzyme Technologies Ltd Growth
|
Compounded Profit Growth |
---|
10 Years:: | 8% |
5 Years:: | 4% |
3 Years:: | -6% |
TTM:: | 32% |
Advanced Enzyme Technologies Ltd Growth
|
Stock Price CAGR |
---|
10 Years:: | % |
5 Years:: | 16% |
3 Years:: | 1% |
1 Year:: | 13% |
Advanced Enzyme Technologies Ltd Growth
|
Return on Equity |
---|
10 Years:: | 16% |
5 Years:: | 14% |
3 Years:: | 12% |
Last Year:: | 9% |
Advanced Enzyme Technologies Ltd Balance Sheet
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
---|
Equity Capital | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
Reserves | 75 | 140 | 145 | 188 | 256 | 442 | 537 | 657 | 817 | 949 | 1,066 | 1,213 | 1,226 |
Borrowings | 207 | 186 | 167 | 115 | 101 | 54 | 67 | 35 | 28 | 28 | 35 | 34 | 39 |
Other Liabilities | 46 | 48 | 73 | 92 | 71 | 65 | 102 | 91 | 104 | 150 | 137 | 142 | 157 |
Total Liabilities | 349 | 396 | 406 | 417 | 450 | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,444 |
Fixed Assets | 204 | 287 | 287 | 287 | 285 | 421 | 491 | 495 | 563 | 604 | 619 | 649 | 653 |
CWIP | 60 | 2 | 2 | 5 | 7 | 8 | 11 | 10 | 10 | 10 | 15 | 22 | 17 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 111 | 124 | 121 | 102 | 360 | 342 |
Other Assets | 84 | 107 | 117 | 125 | 158 | 153 | 226 | 188 | 275 | 414 | 524 | 380 | 432 |
Total Assets | 349 | 396 | 406 | 417 | 450 | 583 | 727 | 805 | 971 | 1,149 | 1,260 | 1,411 | 1,444 |
Advanced Enzyme Technologies Ltd Reserves and Borrowings Chart
Advanced Enzyme Technologies Ltd Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Cash from Operating Activity | 49 | 41 | 43 | 54 | 93 | 107 | 116 | 129 | 141 | 163 | 122 | 140 |
Cash from Investing Activity | -187 | -40 | -25 | -15 | -10 | -60 | -60 | -124 | -43 | -27 | 2 | -286 |
Cash from Financing Activity | 128 | -3 | -20 | -36 | -63 | -65 | -2 | -43 | -39 | -26 | -48 | -26 |
Net Cash Flow | -10 | -2 | -1 | 2 | 21 | -18 | 54 | -38 | 60 | 109 | 75 | -171 |
|
Advanced Enzyme Technologies Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Advanced Enzyme Technologies Ltd Shareholding Pattern Chart
No. of Advanced Enzyme Technologies Ltd Shareholders
Advanced Enzyme Technologies Ltd Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) |
---|
HDFC Small Cap Fund - Regular Plan | 3979689 | 0.58 | 130.55 |
ICICI Prudential ESG Fund | 1000321 | 2.55 | 32.82 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 860609 | 0.89 | 28.23 |
ICICI Prudential Value Discovery Fund | 644400 | 0.06 | 21.14 |
HDFC Multi Cap Fund | 507664 | 0.2 | 16.65 |
ICICI Prudential Equity & Debt Fund | 115918 | 0.02 | 3.8 |
Motilal Oswal S&P BSE Healthcare ETF | 388 | 0.16 | 0.01 |
Advanced Enzyme Technologies Ltd ROCE Trend
Advanced Enzyme Technologies Ltd EPS Trend
Advanced Enzyme Technologies Ltd Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | 9.45 | 10.70 | 13.09 | 11.58 | 9.95 |
Diluted EPS (Rs.) | 9.45 | 10.68 | 13.07 | 11.56 | 9.94 |
Cash EPS (Rs.) | 12.42 | 14.20 | 16.10 | 14.22 | 12.27 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 114.84 | 102.00 | 92.25 | 77.67 | 63.13 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 114.84 | 102.00 | 92.25 | 77.67 | 63.13 |
Revenue From Operations / Share (Rs.) | 48.35 | 47.35 | 44.92 | 39.76 | 37.58 |
PBDIT / Share (Rs.) | 16.27 | 18.59 | 21.51 | 18.62 | 16.74 |
PBIT / Share (Rs.) | 13.13 | 15.46 | 18.97 | 16.31 | 14.85 |
PBT / Share (Rs.) | 12.55 | 15.30 | 18.83 | 16.04 | 14.51 |
Net Profit / Share (Rs.) | 9.29 | 11.07 | 13.56 | 11.91 | 10.38 |
NP After MI And SOA / Share (Rs.) | 9.45 | 10.70 | 13.08 | 11.58 | 9.95 |
PBDIT Margin (%) | 33.64 | 39.26 | 47.89 | 46.84 | 44.55 |
PBIT Margin (%) | 27.16 | 32.65 | 42.23 | 41.03 | 39.52 |
PBT Margin (%) | 25.96 | 32.31 | 41.91 | 40.35 | 38.60 |
Net Profit Margin (%) | 19.21 | 23.38 | 30.18 | 29.96 | 27.62 |
NP After MI And SOA Margin (%) | 19.53 | 22.58 | 29.13 | 29.12 | 26.46 |
Return on Networth / Equity (%) | 8.55 | 10.98 | 15.06 | 15.39 | 16.35 |
Return on Capital Employeed (%) | 10.92 | 14.31 | 19.53 | 19.94 | 22.39 |
Return On Assets (%) | 7.42 | 9.43 | 12.68 | 13.21 | 13.69 |
Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 |
Asset Turnover Ratio (%) | 0.33 | 0.32 | 0.38 | 0.40 | 0.40 |
Current Ratio (X) | 9.31 | 10.00 | 7.64 | 5.85 | 4.07 |
Quick Ratio (X) | 7.71 | 8.00 | 6.25 | 4.62 | 2.98 |
Inventory Turnover Ratio (X) | 1.23 | 1.30 | 1.32 | 1.38 | 1.20 |
Dividend Payout Ratio (NP) (%) | 10.58 | 8.41 | 4.58 | 5.18 | 5.02 |
Dividend Payout Ratio (CP) (%) | 7.94 | 6.50 | 3.83 | 4.32 | 4.22 |
Earning Retention Ratio (%) | 89.42 | 91.59 | 95.42 | 94.82 | 94.98 |
Cash Earning Retention Ratio (%) | 92.06 | 93.50 | 96.17 | 95.68 | 95.78 |
Interest Coverage Ratio (%) | 75.13 | 115.72 | 150.80 | 68.50 | 48.31 |
Interest Coverage Ratio (Post Tax) (%) | 45.58 | 69.93 | 96.02 | 44.82 | 30.95 |
Enterprise Value (Cr.) | 2529.42 | 2942.98 | 3729.91 | 1560.37 | 2073.02 |
EV / Net Operating Revenue (X) | 4.68 | 5.56 | 7.43 | 3.51 | 4.94 |
EV / EBITDA (X) | 13.91 | 14.16 | 15.52 | 7.50 | 11.09 |
MarketCap / Net Operating Revenue (X) | 4.79 | 5.96 | 7.68 | 3.60 | 4.87 |
Retention Ratios (%) | 89.41 | 91.58 | 95.41 | 94.81 | 94.97 |
Price / BV (X) | 2.10 | 2.90 | 3.97 | 1.90 | 3.01 |
Price / Net Operating Revenue (X) | 4.79 | 5.96 | 7.68 | 3.60 | 4.87 |
EarningsYield | 0.04 | 0.03 | 0.03 | 0.08 | 0.05 |
Advanced Enzyme Technologies Ltd Profitability Ratios (%)
Advanced Enzyme Technologies Ltd Liquidity Ratios
Advanced Enzyme Technologies Ltd Liquidity Ratios (%)
Advanced Enzyme Technologies Ltd Interest Coverage Ratios (%)
Advanced Enzyme Technologies Ltd Valuation Ratios
Strength and Weakness of Advanced Enzyme Technologies Ltd Stock
Unable to fetch valid data for stock valuation.